| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0077 | 0.9 |